The "2026 China Ophthalmic Market Report” now includes expanded coverage of China's evolving regulatory environment, with analysis of key reforms implemented in 2025 and 2026 and their implications for ophthalmic manufacturers and providers. The report also adds regional mapping of China's ophthalmologist workforce, updated disease prevalence forecasts, and enhanced market projections across all major ophthalmic segments.
Additional new analysis includes an assessment of IOL manufacturer performance in the years following volume-based procurement, as well as a forecast of anti-VEGF sales by molecule class. Product references have been expanded to include a broader range of domestically developed Chinese products, and company coverage has been enhanced with updated profiles and strategic analysis of both established market leaders and emerging Chinese competitors.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.